Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa

BACKGROUND: Mortality from cryptoccocal meningitis remains high. The ACTA trial demonstrated that, compared with 2 weeks of amphotericin B (AmB) plus flucystosine (5FC), 1 week of AmB and 5FC was associated with lower mortality and 2 weeks of oral flucanozole (FLU) plus 5FC was non-inferior. Here, w...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Infect Dis
Päätekijät: Chen, Tao, Mwenge, Lawrence, Lakhi, Shabir, Chanda, Duncan, Mwaba, Peter, Molloy, Síle F, Gheorghe, Adrian, Griffiths, Ulla K, Heyderman, Robert S, Kanyama, Cecilia, Kouanfack, Charles, Mfinanga, Sayoki, Chan, Adrienne K, Temfack, Elvis, Kivuyo, Sokoine, Hosseinipour, Mina C, Lortholary, Olivier, Loyse, Angela, Jaffar, Shabbar, Harrison, Thomas S, Niessen, Louis W
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2019
Aiheet:
Articles and Commentaries
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6669289/
https://ncbi.nlm.nih.gov/pubmed/30863852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy971
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia